DARE UK Multi-party trusted research environment federation

Establishing infrastructure for secure analysis across different clinical-genomic datasets – frequently asked questions

Introducing the DARE UK Federated Genomics project

Many research institutions and data providers use computing environments known as ‘trusted research environments’ (TREs) as a way to safely analyse data. However, these individual TREs currently cannot easily be used in combination when researchers would like to make use of data that is held within different TREs. Moving data from one TRE into another across organisations is costly, time consuming and full of barriers when meeting different organisations’ governance policies. The ability to analyse datasets held across different organisations could be very valuable to supporting research.

We have been funded by UK Research & Innovation as part of Phase 1 of the DARE UK (Data and Analytics Research Environments UK) programme, delivered in partnership with Health Data Research UK (HDR UK) and ADR UK (Administrative Data Research UK) to demonstrate a UK-first federation of genomic data by bridging the TRE of CYNAPSE, the new data infrastructure for the Cambridge Biomedical Campus, led by the University of Cambridge, with that of Genomics England.

We will do this by developing technologies that allow datasets held in these independent locations to be analysed simultaneously. The results of the separate analyses can then be combined without the original data ever having to move. The outcomes of this project will help establish new standards for federated TRE systems and unlock unprecedented possibilities for future collaborations with clinical-genomic data, potentially leading to new discoveries with long term public benefit.

Who is involved in the project and what are the timelines?

The project partners are the University of Cambridge, NIHR Cambridge Biomedical Research Centre, Genomics England, Eastern AHSN, Cambridge University Health Partners, and Lifebit. Phase 1 of the project started in January 2022, and it will run until the end of August 2022.

How does this fit into CYNAPSE?

The CYNAPSE programme will transform Cambridge’s computer infrastructure into a modern, future-proofed environment, supporting new approaches to clinical research across the Cambridge Biomedical Campus. One of the biggest components of the CYNAPSE programme will be to allow connectivity between datasets held within different research organisations TRE without the need to move datasets (known as ‘multi-party federation’).

The DARE UK Federated Genomic project, a stand-alone, separately funded project, will be a single pilot demonstration to test whether researchers can access and analyse data that is held in the two protected areas of CYNAPSE and Genomics England. The figure below shows where the DARE UK project fits into the CYNAPSE programme timeline.

Graphic showing CYNAPSE project timeline

What is federation of TREs?

Federation is the process of data being analysed using a piece of computer code (instructions to make the computer carry out a specific task). The code is designed to run the same analysis simultaneously in the separate TREs that hold the data researchers are interested in. The results are then brought together centrally in a separate TRE for final review, meaning the data never has to move.

What data is being used and where does it come from?

For the initial (proof of concept) project, both data sources are fully consented clinical-genomic data. Clinical-genomics is the study of clinical outcomes (measurable changes in health, function or quality of life that result from our care) with genomic data (study of the complete set of DNA in a person or other organism) The study of this data helps researchers understand the genetic basis for disease, resulting in more effective treatments.

The dataset from CYNAPSE is anonymous and already in the public domain and permission has been granted by Genomics England for the lead researcher of this project (Professor Serena Nik-Zainal) to run the analysis in question using the Genomics England dataset.

What are the benefits of TRE federation?

Data has the power to improve lives and has been fundamental to the UK’s response to the Covid-19 pandemic. Being able to support fast and efficient advanced analysis of data in an ethical and secure manner, whilst meeting the needs of researchers and data controllers, will support research at scale for the benefit of the public.

What governance procedures need to be addressed to allow for federation?

In the case of the DARE UK Federated Genomics project, the two datasets being used are from CYNAPSE, the data infrastructure for the Cambridge Biomedical Campus, and Genomics England. Both of the steps below would need to be completed before you would be able to federate the data between both organisations.

Requests for access to data from CYNAPSE would need to be approved by the Service Delivery Team who will check that the proposed access is safe and appropriate.

Genomics England datasets cannot be accessed without applying for access for a specific research project. Following approval by the Data Access Review Committee, and successful information governance training, researchers can access data within Genomics England’s secure research environment.

How do you ensure that data is not shared between the TREs?

The DARE UK system will form a virtual link between two TREs, with controls in place to ensure that data does not move between either location, only the combined results of the analysis. A preapproved computer code will allow the analysis to run in both TREs.

The main aim of the project is to show that it is possible to analyse the clinical genomic data safely and securely across these two locations using this method, leading to the development of a best practice model for future federated analytics.

Is there scope for this to be replicated with other organisations/datasets?

Yes, if successful, this initial prototype will serve as a blueprint, establishing the necessary best practices, frameworks, and open-source standards to inform how federated TREs can be used securely and transparently for large scale research.

Is there a patient and public involvement and engagement (PPIE) element in the governance structure or will there be in the future?

Yes, patient/public contributors from both NIHR Cambridge BRC and Genomics England have been involved in developing the governance and oversight framework of this project and we have patient representation within the project teams and attending project meetings.

Have people consented to the use of their data in this way?

The patient data in this project comes from individuals who have already consented to share their information for a particular research project. As this project will not be linking the two datasets but instead allowing for the results from the two to be analysed alongside each other (meaning the data does not move), the consent covers this process.

The NIHR Cambridge BRC is part of the NIHR and hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge. We are at the heart of the Cambridge Biomedical Campus, Europe’s largest health research area.

Bluesky

Contact Us

Cambridge Biomedical Research Centre
Box 277
Hills Road
Cambridge
CB2 0QQ

Tel: 01223 348490

NIHR Cambridge Biomedical Research Centre @cambridgebrc ·

Our Regional PPI Week is back - with 6 AMAZING days of online & in-person activities 9-14 June. Use the QR code to find out what's going on @CamBioCampus, go to @AngliaRuskin's http://shaperesearchtogether.eventbrite.co.uk & visit our stall @CambridgePride @CUH_NHS @Cambridge_Uni @NIHRresearch

Reply on Twitter 1925857237311905988 Retweet on Twitter 1925857237311905988 Like on Twitter 1925857237311905988 Twitter 1925857237311905988

NIHR Cambridge Biomedical Research Centre @cambridgebrc ·

22 May

How can we help the brain to restore hearing? Our Devices & Advanced Therapies Theme Co-Lead Deborah Vickers explores this at her professorship inaugural lecture 19 June 5-8pm at @stjohnscam. FREE in-person & online - see QR code to book @CamNeuro @CUH_NHS @GSTTresearch @BCIG_UK

Reply on Twitter 1925511353889947997 Retweet on Twitter 1925511353889947997 Like on Twitter 1925511353889947997 1 Twitter 1925511353889947997

NIHR Cambridge Biomedical Research Centre @cambridgebrc ·

22 May

🚨 New research shows enhanced breast screening for women with dense breasts could save 700 lives a year 🚨
Cambridge BRAID trial tested different scanning methods in addition to mammograms to detect breast cancers
>> https://bit.ly/3YXqWF0
@CUH_NHS @Cambridge_Uni @NIHRresearch

Reply on Twitter 1925457030019518513 Retweet on Twitter 1925457030019518513 Like on Twitter 1925457030019518513 6 Twitter 1925457030019518513

Retweet on Twitter NIHR Cambridge Biomedical Research Centre Retweeted

CRUK Cambridge Centre @crukcamcentre ·

21 May

📢 Don’t miss our next Cancer Biology and Medicine talk tomorrow!

Oncogene-induced senescence and tumour iniation
Prof Masashi Narita @CRUK_CI

Thurs 22 May, 9:30-10:30
TC Lecture Theatre, School of Clinical Medicine
All welcome @clinical_hr @CambridgeBRC

Reply on Twitter 1925212489454592323 Retweet on Twitter 1925212489454592323 1 Like on Twitter 1925212489454592323 Twitter 1925212489454592323

NIHR Cambridge Biomedical Research Centre @cambridgebrc ·

21 May

👉 Researcher based in Cambridge/ East of England?
👉 Want to learn about Ethnicity inclusion in research training?
👉 04 June - 12.30 - 14.00 (online)
👉 Last few places! Book now! georgina.norris3@nhs.net
@CUH_NHS @Cambridge_Uni @CamNeuro @MRC_Epid @SCICambridge @NIHRresearch

NIHR Cambridge Biomedical Research Centre @CambridgeBRC

➡️ Researcher based in EoE or Oxford?
➡️Interested in Ethnicity inclusion in research training?
📅 04 June ⏰12.30 - 2pm
🗣️Speakers: @Roisin_MM - Dept Psychiatry, Oxford @shauntreweek - Prof. Health Services, Aberdeen
BOOK VIA: georgina.norris3@nhs.net
@CUH_NHS @Cambridge_Uni

Reply on Twitter 1925154627785269410 Retweet on Twitter 1925154627785269410 2 Like on Twitter 1925154627785269410 3 Twitter 1925154627785269410

NIHR Cambridge Biomedical Research Centre @cambridgebrc ·

20 May

If you haven't already, do pop down and see us for International Clinical Trials Day! We are in @CUH_NHS Outpatients until 14.00!
Find out about how to #BePartOfResearch with @CambridgeCRF @NIHRBioResource @NIHRresearch

@CamBioCampus @Cambridge_Uni @RoyalPapworth #ICTD2025

Reply on Twitter 1924797714144927871 Retweet on Twitter 1924797714144927871 1 Like on Twitter 1924797714144927871 10 Twitter 1924797714144927871

View more Tweets

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

DARE UK Multi-party trusted research environment federation

Introducing the DARE UK Federated Genomics project

Who is involved in the project and what are the timelines?

How does this fit into CYNAPSE?

What is federation of TREs?

What data is being used and where does it come from?

What are the benefits of TRE federation?

What governance procedures need to be addressed to allow for federation?

How do you ensure that data is not shared between the TREs?

Is there scope for this to be replicated with other organisations/datasets?

Is there a patient and public involvement and engagement (PPIE) element in the governance structure or will there be in the future?

Have people consented to the use of their data in this way?

Contact Us

Useful Links